# A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)

> **NCT03882996** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 432 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Ezetimibe
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT03882996
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10-06
- **Primary completion:** 2003-02-04
- **Final completion:** 2003-02-04
- **Target enrollment:** 432 (ACTUAL)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03882996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03882996, "A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03882996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*